BIOREM INC (BRM.CA) Stock Fundamental Analysis

Canada • TSX Venture Exchange • TSX-V:BRM • CA09068G1046

2.66 CAD
+0.02 (+0.76%)
Last: Feb 4, 2026, 07:00 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to BRM. BRM was compared to 24 industry peers in the Commercial Services & Supplies industry. BRM gets an excellent profitability rating and is at the same time showing great financial health properties. BRM has a correct valuation and a medium growth rate. These ratings could make BRM a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • BRM had positive earnings in the past year.
  • In the past year BRM had a positive cash flow from operations.
  • BRM had positive earnings in each of the past 5 years.
  • Each year in the past 5 years BRM had a positive operating cash flow.
BRM.CA Yearly Net Income VS EBIT VS OCF VS FCFBRM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M 3M 4M

1.2 Ratios

  • With an excellent Return On Assets value of 7.60%, BRM belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
  • BRM's Return On Equity of 17.30% is amongst the best of the industry. BRM outperforms 87.50% of its industry peers.
  • With an excellent Return On Invested Capital value of 15.98%, BRM belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for BRM is significantly above the industry average of 5.81%.
  • The last Return On Invested Capital (15.98%) for BRM is well below the 3 year average (25.13%), which needs to be investigated, but indicates that BRM had better years and this may not be a problem.
Industry RankSector Rank
ROA 7.6%
ROE 17.3%
ROIC 15.98%
ROA(3y)9.17%
ROA(5y)8.76%
ROE(3y)32.25%
ROE(5y)35.65%
ROIC(3y)25.13%
ROIC(5y)23.46%
BRM.CA Yearly ROA, ROE, ROICBRM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

  • Looking at the Profit Margin, with a value of 6.08%, BRM is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
  • BRM's Profit Margin has improved in the last couple of years.
  • BRM has a Operating Margin of 8.87%. This is in the better half of the industry: BRM outperforms 79.17% of its industry peers.
  • In the last couple of years the Operating Margin of BRM has grown nicely.
  • BRM has a Gross Margin of 24.25%. This is comparable to the rest of the industry: BRM outperforms 45.83% of its industry peers.
  • BRM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.87%
PM (TTM) 6.08%
GM 24.25%
OM growth 3Y7.19%
OM growth 5YN/A
PM growth 3Y15.35%
PM growth 5YN/A
GM growth 3Y1.79%
GM growth 5Y2.67%
BRM.CA Yearly Profit, Operating, Gross MarginsBRM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • BRM has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • BRM has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for BRM has been reduced compared to 5 years ago.
  • Compared to 1 year ago, BRM has an improved debt to assets ratio.
BRM.CA Yearly Shares OutstandingBRM.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BRM.CA Yearly Total Debt VS Total AssetsBRM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

  • An Altman-Z score of 3.92 indicates that BRM is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 3.92, BRM belongs to the best of the industry, outperforming 95.83% of the companies in the same industry.
  • BRM has a debt to FCF ratio of 1.39. This is a very positive value and a sign of high solvency as it would only need 1.39 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.39, BRM belongs to the top of the industry, outperforming 95.83% of the companies in the same industry.
  • BRM has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
  • BRM's Debt to Equity ratio of 0.20 is amongst the best of the industry. BRM outperforms 87.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.39
Altman-Z 3.92
ROIC/WACC2.08
WACC7.68%
BRM.CA Yearly LT Debt VS Equity VS FCFBRM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

  • A Current Ratio of 1.89 indicates that BRM should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.89, BRM belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
  • BRM has a Quick Ratio of 1.73. This is a normal value and indicates that BRM is financially healthy and should not expect problems in meeting its short term obligations.
  • BRM's Quick ratio of 1.73 is amongst the best of the industry. BRM outperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.89
Quick Ratio 1.73
BRM.CA Yearly Current Assets VS Current LiabilitesBRM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • BRM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -64.28%.
  • The Earnings Per Share has been growing by 32.08% on average over the past years. This is a very strong growth
  • The Revenue for BRM has decreased by -24.88% in the past year. This is quite bad
  • Measured over the past years, BRM shows a quite strong growth in Revenue. The Revenue has been growing by 12.63% on average per year.
EPS 1Y (TTM)-64.28%
EPS 3Y32.08%
EPS 5YN/A
EPS Q2Q%-47.19%
Revenue 1Y (TTM)-24.88%
Revenue growth 3Y15.2%
Revenue growth 5Y12.63%
Sales Q2Q%-24.4%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.40% on average over the next years. This is a very strong growth
  • BRM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.68% yearly.
EPS Next Y5.26%
EPS Next 2Y21.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.42%
Revenue Next 2Y10.68%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BRM.CA Yearly Revenue VS EstimatesBRM.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
BRM.CA Yearly EPS VS EstimatesBRM.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.05 0.1 0.15 0.2 0.25

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • BRM is valuated rather expensively with a Price/Earnings ratio of 24.18.
  • Based on the Price/Earnings ratio, BRM is valued a bit cheaper than 75.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 28.25, BRM is valued at the same level.
  • With a Price/Forward Earnings ratio of 9.22, the valuation of BRM can be described as very reasonable.
  • BRM's Price/Forward Earnings ratio is rather cheap when compared to the industry. BRM is cheaper than 95.83% of the companies in the same industry.
  • BRM's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.50.
Industry RankSector Rank
PE 24.18
Fwd PE 9.22
BRM.CA Price Earnings VS Forward Price EarningsBRM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BRM is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
  • 75.00% of the companies in the same industry are more expensive than BRM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.21
EV/EBITDA 10.42
BRM.CA Per share dataBRM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BRM does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of BRM may justify a higher PE ratio.
  • BRM's earnings are expected to grow with 21.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.59
PEG (5Y)N/A
EPS Next 2Y21.4%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • BRM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BIOREM INC

TSX-V:BRM (2/4/2026, 7:00:00 PM)

2.66

+0.02 (+0.76%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-26
Earnings (Next)04-14
Inst Owners0.16%
Inst Owner ChangeN/A
Ins Owners2%
Ins Owner ChangeN/A
Market Cap42.75M
Revenue(TTM)34.73M
Net Income(TTM)2.11M
Analysts84.44
Price Target3.57 (34.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)11.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.29%
Valuation
Industry RankSector Rank
PE 24.18
Fwd PE 9.22
P/S 1.23
P/FCF 19.21
P/OCF 16.63
P/B 3.51
P/tB 3.51
EV/EBITDA 10.42
EPS(TTM)0.11
EY4.14%
EPS(NY)0.29
Fwd EY10.84%
FCF(TTM)0.14
FCFY5.21%
OCF(TTM)0.16
OCFY6.01%
SpS2.16
BVpS0.76
TBVpS0.76
PEG (NY)4.59
PEG (5Y)N/A
Graham Number1.37
Profitability
Industry RankSector Rank
ROA 7.6%
ROE 17.3%
ROCE 21.09%
ROIC 15.98%
ROICexc 37.31%
ROICexgc 37.31%
OM 8.87%
PM (TTM) 6.08%
GM 24.25%
FCFM 6.41%
ROA(3y)9.17%
ROA(5y)8.76%
ROE(3y)32.25%
ROE(5y)35.65%
ROIC(3y)25.13%
ROIC(5y)23.46%
ROICexc(3y)41.23%
ROICexc(5y)N/A
ROICexgc(3y)41.23%
ROICexgc(5y)N/A
ROCE(3y)33.17%
ROCE(5y)30.97%
ROICexgc growth 3Y-30.69%
ROICexgc growth 5YN/A
ROICexc growth 3Y-30.69%
ROICexc growth 5YN/A
OM growth 3Y7.19%
OM growth 5YN/A
PM growth 3Y15.35%
PM growth 5YN/A
GM growth 3Y1.79%
GM growth 5Y2.67%
F-Score4
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.39
Debt/EBITDA 0.67
Cap/Depr 66.81%
Cap/Sales 0.99%
Interest Coverage 250
Cash Conversion 71.47%
Profit Quality 105.47%
Current Ratio 1.89
Quick Ratio 1.73
Altman-Z 3.92
F-Score4
WACC7.68%
ROIC/WACC2.08
Cap/Depr(3y)93.69%
Cap/Depr(5y)79.96%
Cap/Sales(3y)1.3%
Cap/Sales(5y)1.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-64.28%
EPS 3Y32.08%
EPS 5YN/A
EPS Q2Q%-47.19%
EPS Next Y5.26%
EPS Next 2Y21.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-24.88%
Revenue growth 3Y15.2%
Revenue growth 5Y12.63%
Sales Q2Q%-24.4%
Revenue Next Year5.42%
Revenue Next 2Y10.68%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-59.97%
EBIT growth 3Y23.48%
EBIT growth 5YN/A
EBIT Next Year33.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-8.22%
FCF growth 3Y-3.66%
FCF growth 5Y6.73%
OCF growth 1Y-18.62%
OCF growth 3Y-0.86%
OCF growth 5Y7.83%

BIOREM INC / BRM.CA FAQ

What is the fundamental rating for BRM stock?

ChartMill assigns a fundamental rating of 7 / 10 to BRM.CA.


What is the valuation status of BIOREM INC (BRM.CA) stock?

ChartMill assigns a valuation rating of 6 / 10 to BIOREM INC (BRM.CA). This can be considered as Fairly Valued.


How profitable is BIOREM INC (BRM.CA) stock?

BIOREM INC (BRM.CA) has a profitability rating of 9 / 10.


What is the expected EPS growth for BIOREM INC (BRM.CA) stock?

The Earnings per Share (EPS) of BIOREM INC (BRM.CA) is expected to grow by 5.26% in the next year.